What Medications Can Cause Pancreatitis?

Dozens of prescription and over-the-counter medications have been linked to acute pancreatitis, though drugs account for a small share of all cases, roughly 0.1 to 2 percent by most estimates.¹ The list of implicated agents runs long and spans nearly every drug class, from common antibiotics to chemotherapy agents to herbal weight-loss supplements. Because drug-induced pancreatitis has no unique symptoms that separate it from gallstone or alcohol-related pancreatitis, many cases are missed or attributed to something else entirely.

How Common Is Drug-Induced Pancreatitis?

In a study that tracked over 1,600 patients treated for acute pancreatitis in a single year, drugs were identified as the cause in about 1.4 percent of cases, and the episodes tended to be mild compared with pancreatitis from other causes.² That low figure likely underestimates reality. Most evidence linking specific drugs to pancreatitis comes from scattered case reports rather than large trials, and the clinical picture looks identical to pancreatitis caused by gallstones or heavy drinking. A doctor may never suspect a medication if a more common explanation seems plausible.³ When researchers combed the FDA’s adverse event database from 2004 through 2022, they found over 62,000 reports of acute pancreatitis implicating more than 1,100 different drugs, with metformin, quetiapine, liraglutide, exenatide, and sitagliptin topping the list by sheer volume of reports.⁴ Volume of reports does not automatically mean a drug is more dangerous to the pancreas; it also reflects how widely a drug is prescribed and how carefully side effects are tracked for it.

How Researchers Rank the Evidence

Not every drug accused of causing pancreatitis has equally strong evidence behind it. Researchers have developed a four-tier classification to sort through the noise. The strongest category includes drugs where a patient developed pancreatitis, recovered after the drug was stopped, and then developed pancreatitis again when the drug was restarted. That rechallenge pattern is the closest thing to proof in the absence of a controlled experiment. The next tier includes drugs where large observational or case-control studies consistently link them to pancreatitis. Below that sit drugs supported only by multiple case reports with no rechallenge or consistent timing, and at the bottom are drugs with just a single published case.⁵ A revised version of this classification in 2023 kept the same basic structure, emphasizing that randomized trial data sits at the top while isolated case reports deserve the most skepticism.⁶

This tiered approach matters for you as a patient. If your doctor suspects a medication is causing pancreatitis, a drug in the top tier with rechallenge evidence is a strong signal. A drug in the bottom tier, with only one published case report, is far less certain, and other causes need to be ruled out thoroughly before pointing the finger.

The Major Drug Categories With the Strongest Links

Across decades of case reports, observational studies, and pharmacovigilance data, certain drug categories appear consistently. The following groups have the most convincing evidence behind them, though the specific mechanism of pancreatic injury varies from one class to another.

Immunosuppressants

Azathioprine is one of the best-documented offenders. It is widely used in inflammatory bowel disease and after organ transplants, and pancreatitis from azathioprine tends to show up early, often within weeks of starting the drug. The reaction appears to be a hypersensitivity response rather than a dose-dependent toxic effect. Case reports describe patients developing pancreatitis alongside other signs of an immune reaction, with symptoms resolving once the drug is stopped.⁷ Researchers have documented cases where azathioprine triggered inflammation simultaneously in the pancreas and salivary glands, suggesting a shared immune-mediated mechanism across glandular tissue.⁸

Tacrolimus, another immunosuppressant used after kidney transplants, has also been linked to pancreatitis, though with fewer reports. In at least one documented case, a transplant patient developed pancreatitis when tacrolimus blood levels climbed too high, and symptoms resolved after switching to a different immunosuppressant.⁹

Anticonvulsants, Especially Valproic Acid

Valproic acid, commonly prescribed for epilepsy, bipolar disorder, and migraine prevention, is a definite cause of pancreatitis and is one of the most frequently implicated drugs in children. Research suggests valproic acid may not damage the pancreas directly through toxicity but rather by interfering with the organ’s ability to recover from minor insults. By blocking certain enzymes involved in how cells regulate gene activity, valproic acid appears to stall the process by which pancreatic cells repair themselves and return to normal function after injury.¹⁰ In a study of 271 children with pancreatitis, drugs were involved in about a quarter of cases, and valproic acid and corticosteroids were the most commonly associated medications. Valproic acid was especially common in younger children under 11.¹¹

Certain Antibiotics

Metronidazole, a widely used antibiotic for infections ranging from dental abscesses to intestinal parasites, carries a notably elevated pancreatitis risk. A population-based study found that taking metronidazole within the previous 30 days was associated with roughly a fourfold increase in pancreatitis risk for the drug alone, and an even higher risk when it was combined with other medications in a treatment regimen.¹² The mechanism is not fully understood, but researchers suspect it involves free radical damage during an inflammatory immune response in the pancreas.¹³

Ceftriaxone, a common injectable antibiotic, causes pancreatitis through an entirely different route. It binds to calcium in the bile and forms sludge-like deposits in the gallbladder, a phenomenon sometimes called pseudolithiasis. These deposits can block the pancreatic duct in the same way a real gallstone would, triggering pancreatitis. The condition is seen more often in children than adults, and the sludge usually disappears on its own once the antibiotic course ends.¹⁴

Antiretrovirals for HIV

Pancreatitis has long been a recognized complication of HIV treatment, particularly with older antiretroviral drugs. The nucleoside reverse transcriptase inhibitors didanosine and stavudine are the primary culprits, and the mechanism appears to involve mitochondrial damage in pancreatic cells.¹⁵ Some protease inhibitors used in HIV treatment can also trigger pancreatitis indirectly by causing very high triglyceride levels. Case reports have documented severe outcomes, including lactic acidosis and pancreatitis, in pregnant women who had been on stavudine-containing regimens for extended periods.¹⁶ Modern HIV regimens have largely moved away from these drugs, which has reduced but not eliminated this risk.

Chemotherapy Agents

L-asparaginase, a cornerstone of treatment for acute lymphoblastic leukemia (a type of blood cancer), causes pancreatitis through a metabolic mechanism. It works by depleting a specific amino acid that cancer cells need, but this depletion also starves organs that produce large amounts of protein, including the liver and pancreas. The resulting stress on the pancreas can lead to inflammation. Genetic factors may also play a role in determining which patients are most vulnerable.¹⁷

Drugs That Cause Pancreatitis Indirectly

Some medications do not damage the pancreas directly but create conditions that lead to pancreatitis through secondary pathways. Understanding these indirect mechanisms matters because the solution is sometimes treating the secondary problem rather than simply stopping the drug.

Estrogen-containing medications and fertility drugs can cause dangerous spikes in triglycerides, the type of blood fat most closely linked to pancreatitis when levels climb high enough. Case reports describe patients on estrogen therapy during in vitro fertilization who developed pancreatitis after their triglycerides surged.¹⁸ Clomiphene, a fertility medication, has been associated with the same pattern. In one documented case, a woman’s triglycerides rose nearly twentyfold from baseline after two months of clomiphene use, leading to severe pancreatitis.¹⁹ People who already have elevated triglycerides or poorly controlled diabetes are at the highest risk from these drugs.

ACE inhibitors, a class of blood pressure medication taken by millions, have been linked to pancreatitis through a vascular mechanism. In animal models, these drugs increase the permeability of small blood vessels in the pancreas and reduce blood flow, leading to tissue damage. They also elevate levels of bradykinin, a substance that causes blood vessels to dilate and can trigger swelling within pancreatic tissue.²⁰ The risk appears small in absolute terms, which is important context given how many people take these drugs daily.

The GLP-1 Drug Controversy

GLP-1 receptor agonists, the drug class that includes semaglutide and liraglutide, have generated considerable debate about pancreatic risk since they first reached the market. Early concerns were driven in part by their mechanism of action: these drugs stimulate the pancreas to release insulin, and regulators worried this stimulation could lead to inflammation. Liraglutide and exenatide are among the most frequently reported drugs in FDA adverse event data for pancreatitis.⁴

However, larger and more rigorous studies have painted a more reassuring picture. In a propensity-matched analysis of type 2 diabetes patients without other comorbidities, pancreatitis rates were similar between those on GLP-1 drugs and those on other diabetes medications, and the lifetime risk was actually slightly lower in the GLP-1 group.²¹ A comparative study across multiple diabetes drug classes found no significant difference in pancreatitis risk between GLP-1 drugs and DPP-4 inhibitors or SGLT2 inhibitors, while sulfonylureas actually carried a higher risk.²²

One study did find a modestly higher rate of pancreatitis with GLP-1 drugs compared to DPP-4 inhibitors.²³ The weight of the evidence at this point suggests that if GLP-1 drugs increase pancreatitis risk at all, the effect is very small and may be confounded by the fact that type 2 diabetes itself is an independent risk factor for pancreatitis. For people with a personal history of pancreatitis, though, many clinicians still exercise extra caution before prescribing these drugs.

NSAIDs and Over-the-Counter Painkillers

The relationship between common painkillers and pancreatitis contains an irony that catches some people off guard. NSAIDs like ibuprofen are used to treat pain from pancreatitis, and they are generally considered safe for the pancreas. But in extremely rare instances, NSAIDs themselves have been implicated as the cause. A case report documented a patient who developed pancreatitis after three weeks of daily ibuprofen for chronic shoulder pain, with all other causes ruled out.²⁴ This is an exceptionally uncommon event, and the risk should not discourage short-term use of these drugs for normal aches and pains. But for anyone taking NSAIDs daily over long stretches, it is worth being aware of.

Herbal Supplements and the Unregulated Gray Area

Prescription drugs get the most attention, but herbal supplements and over-the-counter products occupy a troubling blind spot. Because these products are not regulated with the same rigor as pharmaceuticals, their ingredients may be inconsistent, poorly studied, or contaminated with unlisted substances. Case reports have connected pancreatitis to herbal weight-loss supplements, Garcinia cambogia (a popular ingredient in diet products), and supplements marketed for libido enhancement.²⁵ Additional reports document pancreatitis in patients taking herbal medications for weight loss and osteoarthritis.²⁶

Chromium-containing supplements, widely available over the counter and marketed for blood sugar control or weight management, have also come under scrutiny. A recent report described a patient who developed pancreatitis after starting a supplement that combined chromium polynicotinate with herbal additives.²⁷ The broader concern is that many people do not think of supplements as “real” medications and fail to mention them when a doctor asks what they are taking. If you develop pancreatitis with no obvious cause, your doctor should know about every supplement in your cabinet.

Why Drug-Induced Pancreatitis Is So Hard to Diagnose

The core diagnostic challenge is that drug-induced pancreatitis looks, feels, and shows up on lab tests exactly like pancreatitis from any other cause. There is no blood marker, imaging finding, or biopsy result that says “a drug did this.” The diagnosis is made by exclusion: a doctor has to rule out gallstones, alcohol, high triglycerides, infections, anatomical abnormalities, and autoimmune causes. Only when all of those are off the table does the medication list come under scrutiny.¹

Even then, the timing has to make sense. Did the pancreatitis develop within a plausible window after starting the drug? Did it resolve when the drug was stopped? These are the questions clinicians work through. Rechallenge, where the drug is deliberately restarted to see if pancreatitis returns, provides the most convincing evidence but is rarely done intentionally because of the risk to the patient. Most rechallenge data in the medical literature comes from accidental re-exposures, where a drug was restarted because nobody suspected it had caused the first episode.

Children Face a Different Risk Profile

Drug-induced pancreatitis accounts for a larger share of cases in children than in adults, likely because children rarely have the gallstone or alcohol-related causes that dominate the adult population. In one pediatric study, medications were associated with about a quarter of all pancreatitis cases, with valproic acid and corticosteroids as the leading culprits.¹¹ Ceftriaxone-related pseudolithiasis is also more commonly reported in children.¹⁴ Parents of children on long-term anticonvulsants or repeated antibiotic courses should be aware of abdominal pain as a symptom that warrants prompt evaluation.

What to Do If You Suspect a Medication

If you experience the hallmarks of pancreatitis, severe upper abdominal pain radiating to the back, nausea, and vomiting, especially within days or weeks of starting a new medication, do not stop the drug on your own without medical guidance. Some medications, particularly anticonvulsants and immunosuppressants, can cause dangerous withdrawal effects if stopped abruptly. Instead, get to a doctor who can evaluate you properly, including blood tests for pancreatic enzymes and imaging.

When talking to your doctor, bring a complete list of everything you take: prescriptions, over-the-counter drugs, vitamins, herbal products, and anything ordered online. Many clinicians will not think to ask about that chromium supplement or Garcinia cambogia capsule unless you volunteer it. If drug-induced pancreatitis is confirmed, the standard approach is to discontinue the offending drug and switch to an alternative. The good news is that drug-induced pancreatitis tends to run a milder course than pancreatitis from other causes and usually resolves once the drug is removed from the equation.² After an episode, the implicated drug should be permanently flagged in your medical record as something you cannot take again, since a second exposure can trigger a faster and potentially more severe recurrence.